Literature DB >> 22770659

Clinical applications of botulinum toxin.

Dirk Dressler1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22770659     DOI： 10.1016/j.mib.2012.05.012

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN： 1369-5274            Impact factor:   7.934


× No keyword cloud information.
  61 in total

Review 1.  Botulinum toxin drugs: brief history and outlook.

Authors:  D Dressler
Journal:  J Neural Transm (Vienna)       Date:  2015-11-11       Impact factor: 3.575

Review 2.  Pharmacotherapy for the management of achalasia: Current status, challenges and future directions.

Authors:  Ammar Nassri; Zeeshan Ramzan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

Review 3.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

4.  Activity of botulinum neurotoxin type D (strain 1873) in human neurons.

Authors:  Sabine Pellett; William H Tepp; Jacob M Scherf; Christina L Pier; Eric A Johnson
Journal:  Toxicon       Date:  2015-04-30       Impact factor: 3.033

Review 5.  A brief history of neurological botulinum toxin therapy in Germany.

Authors:  Dirk Dressler; Peter Roggenkaemper
Journal:  J Neural Transm (Vienna)       Date:  2017-07-21       Impact factor: 3.575

Review 6.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

7.  Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Authors:  Cesare Colasante; Ornella Rossetto; Laura Morbiato; Marco Pirazzini; Jordi Molgó; Cesare Montecucco
Journal:  Mol Neurobiol       Date:  2013-03-08       Impact factor: 5.590

8.  Selective muscle botulinum toxin A component paralysis in complex ventral hernia repair.

Authors:  K E Elstner; J W Read; J Saunders; P H Cosman; O Rodriguez-Acevedo; A S W Jacombs; R T Martins; N Ibrahim
Journal:  Hernia       Date:  2019-04-04       Impact factor: 4.739

9.  The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders.

Authors:  María T Gómez-Caravaca; María T Cáceres-Redondo; Ismael Huertas-Fernández; Laura Vargas-González; Fátima Carrillo; Manuel Carballo; Pablo Mir
Journal:  Neurol Sci       Date:  2014-09-20       Impact factor: 3.307

10.  Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using Botulinum Toxin A.

Authors:  K E Elstner; A S W Jacombs; J W Read; O Rodriguez; M Edye; P H Cosman; A N Dardano; A Zea; T Boesel; D J Mikami; C Craft; N Ibrahim
Journal:  Hernia       Date:  2016-03-07       Impact factor: 4.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.